These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis. Yu-Wai-Man C; Spencer-Dene B; Lee RMH; Hutchings K; Lisabeth EM; Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT Sci Rep; 2017 Mar; 7(1):518. PubMed ID: 28364121 [TBL] [Abstract][Full Text] [Related]
4. Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis. Knipe RS; Nurunnabi M; Probst CK; Spinney JJ; Abe E; Bose RJC; Ha K; Logue A; Nguyen T; Servis R; Drummond M; Haring A; Brazee PL; Medoff BD; McCarthy JR Am J Physiol Lung Cell Mol Physiol; 2023 Feb; 324(2):L190-L198. PubMed ID: 36625494 [TBL] [Abstract][Full Text] [Related]
5. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway. Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023 [TBL] [Abstract][Full Text] [Related]
6. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury. Haak AJ; Tsou PS; Amin MA; Ruth JH; Campbell P; Fox DA; Khanna D; Larsen SD; Neubig RR J Pharmacol Exp Ther; 2014 Jun; 349(3):480-6. PubMed ID: 24706986 [TBL] [Abstract][Full Text] [Related]
7. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191 [TBL] [Abstract][Full Text] [Related]
9. Expression of serum response factor in the lung mesenchyme is essential for development of pulmonary fibrosis. Bernau K; Leet JP; Bruhn EM; Tubbs AJ; Zhu T; Sandbo N Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L174-L188. PubMed ID: 33978489 [TBL] [Abstract][Full Text] [Related]
10. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis. Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656 [TBL] [Abstract][Full Text] [Related]
11. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692 [TBL] [Abstract][Full Text] [Related]
12. Myocardin-related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts. Yamamura Y; Sakai N; Iwata Y; Lagares D; Hara A; Kitajima S; Toyama T; Miyagawa T; Ogura H; Sato K; Oshima M; Nakagawa S; Tamai A; Horikoshi K; Matsuno T; Yamamoto N; Hayashi D; Toyota Y; Kaikoi D; Shimizu M; Tager AM; Wada T FASEB J; 2023 Jul; 37(7):e23005. PubMed ID: 37289107 [TBL] [Abstract][Full Text] [Related]
14. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice. Kishi M; Aono Y; Sato S; Koyama K; Azuma M; Abe S; Kawano H; Kishi J; Toyoda Y; Okazaki H; Ogawa H; Uehara H; Nishioka Y PLoS One; 2018; 13(12):e0209786. PubMed ID: 30596712 [TBL] [Abstract][Full Text] [Related]
15. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin. Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801 [TBL] [Abstract][Full Text] [Related]
16. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats. Zhang YP; Li WB; Wang WL; Liu J; Song SX; Bai LL; Hu YY; Yuan YD; Zhang M Acta Pharmacol Sin; 2012 Jul; 33(7):897-908. PubMed ID: 22659625 [TBL] [Abstract][Full Text] [Related]
17. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734 [TBL] [Abstract][Full Text] [Related]
18. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis. Mergault C; Lisée F; Tiroille V; Magnien M; Parent C; Lenga Mabonda W; Sizaret D; Jaillet M; Crestani B; Marchand-Adam S; Plantier L Br J Pharmacol; 2022 Jan; 179(1):125-140. PubMed ID: 34453744 [TBL] [Abstract][Full Text] [Related]
20. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway. Wang J; Fang C; Wang S; Fang F; Chu X; Liu N; Lu C; Wang S; Li W J Tradit Chin Med; 2020 Apr; 40(2):236-244. PubMed ID: 32242389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]